Multinational, double-blind, phase III study of prednisone and either satraplatin or placebo in patients with castrate-refractory prostate cancer progressing after prior chemotherapy: the SPARC trial (Q33386511)
scientific article
Language:
(P31) (Q13442814)
(P50) (Q59248240)
(Q50385202)
(Q114529978)
(Q95312566)
(P304) 5431-5438
(P407) (Q1860)
(P433) 32
(P478) 27
(P577) Monday, October 5, 2009
(P921) (Q42824827)
(Q269829)
(Q181600)
(Q974135)
(Q2226212)
(Q181257)
(P1433) (Q400292)
(P1476) "Multinational, double-blind, phase III study of prednisone and either satraplatin or placebo in patients with castrate-refractory prostate cancer progressing after prior chemotherapy: the SPARC trial" (language: en)
(P2093) Daniel P Petrylak
Oliver Sartor
Jean-Marc Ferrero
Jean-Christophe Eymard
Silvia Falcon
Fabio Calabrò
Nicholas James
Istvan Bodrogi
Peter Harper
William Berry
Michael E Petrone
Thomas J McKearn
Mojtaba Noursalehi
Martine George
Marcel Rozencweig
other details
description scientific article

External Links